Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)
Crossref DOI link: https://doi.org/10.1007/s00277-016-2661-7
Published Online: 2016-04-05
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ozaki, Shuji
Hata, Hiroyuki
Abe, Masahiro
Saitoh, Takayuki
Hanamura, Ichiro
Yano, Hiroki
Sunami, Kazutaka
Kosugi, Hiroshi
Sawamura, Morio
Nakazato, Tomonori
Masunari, Taro
Mori, Mayumi
Takagi, Toshiyuki
Murakami, Hirokazu
Shimizu, Kazuyuki
Text and Data Mining valid from 2016-04-05